Reed Group to Launch Drug Formulary Based on ACOEM Practice Guidelines

WESTMINSTER, Colo.--(BUSINESS WIRE)--Reed Group, a leading provider of absence management and publisher of MDGuidelines®, announced today the introduction of a groundbreaking drug formulary based on the American College of Occupational and Environment Medicine (ACOEM) Practice Guidelines. Set to launch as an integrated tool within MDGuidelines in November of 2015, “this innovative drug formulary will be the only formulary within the workers’ compensation arena with therapeutic agent recommendations tied specifically to work-related injuries and illnesses as well as the phase of care, either acute or chronic,” said Senior Vice President of MDGuidelines, Joe Guerriero. About Benicar (Olmesartan) with free prescription “It will be a unique tool to promote quality of care, positive therapeutic outcomes, and safe, cost-effective drug choices.” “By basing this formulary on ACOEM’s Practice Guidelines, the playing field dramatically changes for health care providers and work force managers across the country. Buy Vepesid (Etoposide) with no Rx They now have the better choice of a widely used clinical reference that can provide recommendations for the most appropriate medication therapy for their patients as opposed to relying on a basic drug list,” said Kurt Hegmann, M.D., MPH, Editor-in-Chief of the ACOEM Practice Guidelines. To build this formulary, Reed Group sought a leader in clinically-focused, comprehensive solutions for pharmacy benefit management, Healthesystems, known for their expertise in workers’ compensation drug formulary creation. About Aricept (Donepezil) without prescription Dr. Fulvicin with no Rx Robert Goldberg, M.D., the Chief Medical Officer at Healthesystems, worked in conjunction with pharmacists and Dr. Geodon (Ziprasidone) with no prescription Hegmann. “This formulary will set the standard and shape the future of treatment for workplace injuries and illnesses,” said Dr. Buy Digestion online Goldberg. http://doctor-answers.blogspot.com/ “The ACOEM Practice Guidelines provide an invaluable framework for this formulary’s clinical development and will serve as the foundation to ensure users are guided to the right medication treatment recommendation at the right time. Treatment decisions are far too important to rely on generalized information that is not specific to injury or illness.” Developed by pharmacists and physicians along with input from external peer reviewers, the formulary will provide inclusions and exclusions in an easy-to-understand and updated format for physicians and other health care professionals, including clinical case managers, insurers and third-party administrators. ACOEM’s Practice Guidelines are solely available from Reed Group, making the availability of this drug formulary exclusive to MDGuidelines. The launch of this new drug formulary is one of several upcoming major enhancements to the MDGuidelines suite of products and services. About Reed Group Reed Group, Ltd., a wholly owned subsidiary of The Guardian Life Insurance Company of America®, is the recognized leader in helping organizations reduce the cost, compliance risk and complexity of employee absence. Reed Group is also the publisher of MDGuidelines the only treatment guidelines product based on ACOEM Practice Guidelines. Reed Group’s products and services address FMLA, ADA, state and other leave laws, workers compensation and short- and long-term disability programs. Headquartered in Westminster, Colorado, Reed Group has been a trusted partner to employers, insurers, TPAs, government organizations, attorneys and health care providers for over 35 years. Reed Group s world-class team of clinical and absence management experts help organizations deploy Reed Group products and services to improve employee health and productivity. For more information, visit .reedgroup.com. About Healthesystems Healthesystems is a specialty provider of innovative medical cost management solutions for the workers’ compensation industry. The company’s comprehensive product portfolio includes a leading pharmacy benefit management program (PBM), expert clinical review services, and a revolutionary ancillary benefits management solution (ABM) for prospectively managing ancillary medial services such as durable medical equipment (DME), home health, transportation and translation services. By leveraging innovation, powerful technology, clinical expertise and enhanced workflow automation tools, Healthesystems provides clients with flexible programs that reduce the total cost of medical care while increasing the quality of care for injured workers. To learn more about Healthesystems, visit .healthesystems.com.